| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Granulomatous Disease, Chronic | 3 | 2019 | 60 | 1.09 | Why? |
| Interferon beta-1a | 1 | 2020 | 316 | 0.66 | Why? |
| HIV Protease Inhibitors | 1 | 2020 | 434 | 0.66 | Why? |
| Rhinitis | 2 | 2021 | 626 | 0.65 | Why? |
| Sinusitis | 2 | 2021 | 649 | 0.64 | Why? |
| Aspergillus | 1 | 2018 | 347 | 0.59 | Why? |
| Interferon-beta | 1 | 2020 | 979 | 0.55 | Why? |
| Antibodies, Monoclonal, Humanized | 3 | 2020 | 9335 | 0.54 | Why? |
| Lopinavir | 4 | 2021 | 4308 | 0.53 | Why? |
| Immunologic Factors | 2 | 2020 | 4206 | 0.53 | Why? |
| Antitubercular Agents | 4 | 2017 | 775 | 0.53 | Why? |
| Ritonavir | 4 | 2021 | 4212 | 0.52 | Why? |
| Tuberculosis, Multidrug-Resistant | 3 | 2018 | 433 | 0.47 | Why? |
| DNA, Fungal | 2 | 2021 | 95 | 0.42 | Why? |
| Iran | 11 | 2021 | 5467 | 0.37 | Why? |
| Immunoglobulins, Intravenous | 1 | 2020 | 2705 | 0.36 | Why? |
| Injections, Subcutaneous | 2 | 2020 | 647 | 0.36 | Why? |
| Adrenal Cortex Hormones | 2 | 2021 | 6537 | 0.32 | Why? |
| Mycobacterium bovis | 2 | 2018 | 125 | 0.32 | Why? |
| Antiviral Agents | 6 | 2021 | 41703 | 0.31 | Why? |
| Immunoglobulin M | 3 | 2021 | 9091 | 0.29 | Why? |
| Tuberculosis | 5 | 2019 | 2895 | 0.29 | Why? |
| Interleukin-6 | 4 | 2021 | 7522 | 0.28 | Why? |
| Drug Combinations | 3 | 2021 | 3852 | 0.24 | Why? |
| DNA, Ribosomal Spacer | 1 | 2021 | 49 | 0.23 | Why? |
| Exosomes | 2 | 2019 | 567 | 0.23 | Why? |
| Macrophages | 3 | 2018 | 2784 | 0.22 | Why? |
| Mycoses | 2 | 2019 | 589 | 0.22 | Why? |
| MicroRNAs | 3 | 2019 | 1787 | 0.21 | Why? |
| Psychophysics | 1 | 2020 | 56 | 0.21 | Why? |
| Coinfection | 2 | 2017 | 6820 | 0.21 | Why? |
| Blastocystis | 1 | 2019 | 9 | 0.20 | Why? |
| Blastocystis Infections | 1 | 2019 | 12 | 0.20 | Why? |
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2021 | 229 | 0.20 | Why? |
| Pyrazines | 2 | 2021 | 1783 | 0.20 | Why? |
| Lymphocytosis | 1 | 2021 | 122 | 0.20 | Why? |
| Amides | 2 | 2021 | 1864 | 0.20 | Why? |
| Tetradecanoylphorbol Acetate | 1 | 2018 | 23 | 0.20 | Why? |
| Rhodamines | 1 | 2018 | 19 | 0.20 | Why? |
| Drug Therapy, Combination | 4 | 2021 | 7268 | 0.20 | Why? |
| Gout | 1 | 2020 | 85 | 0.19 | Why? |
| Rifampin | 2 | 2018 | 276 | 0.19 | Why? |
| Ethambutol | 1 | 2018 | 34 | 0.19 | Why? |
| Pyrazinamide | 1 | 2018 | 38 | 0.18 | Why? |
| Mycobacterium tuberculosis | 2 | 2018 | 1164 | 0.18 | Why? |
| Antibiotics, Antitubercular | 1 | 2018 | 65 | 0.18 | Why? |
| Mycobacterium Infections | 1 | 2018 | 72 | 0.18 | Why? |
| Paecilomyces | 1 | 2017 | 9 | 0.18 | Why? |
| Olfaction Disorders | 3 | 2020 | 3704 | 0.17 | Why? |
| Respiratory Tract Infections | 1 | 2018 | 6817 | 0.17 | Why? |
| HIV Infections | 3 | 2018 | 11620 | 0.17 | Why? |
| Cyclosporine | 1 | 2021 | 449 | 0.17 | Why? |
| Tuberculosis, Pulmonary | 2 | 2019 | 1171 | 0.17 | Why? |
| Invasive Fungal Infections | 1 | 2021 | 274 | 0.17 | Why? |
| Matrix Metalloproteinases | 1 | 2018 | 131 | 0.17 | Why? |
| Plasmapheresis | 1 | 2020 | 437 | 0.16 | Why? |
| Lung | 7 | 2021 | 31049 | 0.16 | Why? |
| Adult | 27 | 2021 | 244371 | 0.16 | Why? |
| Granuloma | 1 | 2017 | 88 | 0.16 | Why? |
| Fluoroquinolones | 1 | 2018 | 235 | 0.16 | Why? |
| Sarcoidosis, Pulmonary | 1 | 2017 | 91 | 0.16 | Why? |
| Middle Aged | 26 | 2021 | 270681 | 0.16 | Why? |
| Betacoronavirus | 9 | 2020 | 204454 | 0.16 | Why? |
| Pleura | 1 | 2017 | 178 | 0.15 | Why? |
| Receptors, Pattern Recognition | 1 | 2017 | 128 | 0.15 | Why? |
| DNA Mutational Analysis | 1 | 2018 | 581 | 0.15 | Why? |
| Infusions, Intravenous | 1 | 2020 | 1224 | 0.15 | Why? |
| Male | 29 | 2021 | 367725 | 0.15 | Why? |
| AIDS-Related Opportunistic Infections | 1 | 2017 | 260 | 0.14 | Why? |
| Humans | 47 | 2021 | 930598 | 0.14 | Why? |
| Erythrocytes | 1 | 2020 | 617 | 0.14 | Why? |
| Female | 27 | 2021 | 380317 | 0.13 | Why? |
| Tomography, X-Ray Computed | 5 | 2021 | 25144 | 0.13 | Why? |
| Tumor Necrosis Factor-alpha | 2 | 2021 | 2483 | 0.13 | Why? |
| Pneumonia, Viral | 10 | 2021 | 243684 | 0.13 | Why? |
| Nitric Oxide | 1 | 2020 | 769 | 0.13 | Why? |
| Carbon Dioxide | 1 | 2020 | 917 | 0.13 | Why? |
| Prospective Studies | 5 | 2021 | 43301 | 0.13 | Why? |
| Treatment Outcome | 7 | 2021 | 51732 | 0.13 | Why? |
| Colchicine | 1 | 2020 | 730 | 0.13 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.13 | Why? |
| Immunodominant Epitopes | 1 | 2018 | 813 | 0.12 | Why? |
| Dexamethasone | 2 | 2021 | 2055 | 0.12 | Why? |
| Reactive Oxygen Species | 1 | 2018 | 1136 | 0.12 | Why? |
| Immune System Diseases | 1 | 2017 | 410 | 0.12 | Why? |
| Aged | 17 | 2021 | 215776 | 0.12 | Why? |
| Mucormycosis | 1 | 2021 | 832 | 0.11 | Why? |
| Th1 Cells | 1 | 2018 | 1228 | 0.11 | Why? |
| Fatal Outcome | 1 | 2021 | 3438 | 0.11 | Why? |
| Kaplan-Meier Estimate | 1 | 2020 | 4260 | 0.11 | Why? |
| Lymph Nodes | 1 | 2017 | 1060 | 0.11 | Why? |
| Base Sequence | 1 | 2018 | 3581 | 0.10 | Why? |
| Aged, 80 and over | 7 | 2021 | 88759 | 0.10 | Why? |
| Oxygen | 2 | 2021 | 3715 | 0.10 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2018 | 2309 | 0.10 | Why? |
| Clinical Protocols | 1 | 2020 | 2734 | 0.09 | Why? |
| Dendritic Cells | 1 | 2018 | 1330 | 0.09 | Why? |
| Prisoners | 1 | 2018 | 738 | 0.09 | Why? |
| Bacterial Proteins | 1 | 2018 | 1318 | 0.09 | Why? |
| Lymphopenia | 1 | 2021 | 2669 | 0.09 | Why? |
| Smoking Cessation | 1 | 2017 | 826 | 0.09 | Why? |
| Young Adult | 9 | 2021 | 93724 | 0.09 | Why? |
| Bacterial Infections | 2 | 2019 | 2229 | 0.09 | Why? |
| BCG Vaccine | 1 | 2018 | 1137 | 0.09 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.08 | Why? |
| Noninvasive Ventilation | 1 | 2020 | 2329 | 0.08 | Why? |
| Cough | 1 | 2021 | 4891 | 0.08 | Why? |
| Echocardiography | 1 | 2021 | 3661 | 0.08 | Why? |
| Hydroxychloroquine | 2 | 2020 | 12447 | 0.08 | Why? |
| Cytokines | 4 | 2021 | 15010 | 0.08 | Why? |
| Pandemics | 11 | 2021 | 389249 | 0.08 | Why? |
| Length of Stay | 2 | 2021 | 11042 | 0.08 | Why? |
| Hypoxia | 1 | 2020 | 3626 | 0.07 | Why? |
| Respiration, Artificial | 5 | 2021 | 22116 | 0.07 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.07 | Why? |
| Adolescent | 5 | 2020 | 86841 | 0.07 | Why? |
| Myocarditis | 1 | 2021 | 2731 | 0.07 | Why? |
| Occupational Health | 1 | 2021 | 3965 | 0.07 | Why? |
| Intubation, Intratracheal | 1 | 2020 | 3962 | 0.07 | Why? |
| Treatment Failure | 2 | 2021 | 2106 | 0.07 | Why? |
| ST Elevation Myocardial Infarction | 1 | 2020 | 3051 | 0.06 | Why? |
| Fever | 1 | 2021 | 7795 | 0.06 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.06 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.06 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.06 | Why? |
| Percutaneous Coronary Intervention | 1 | 2020 | 3646 | 0.06 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.06 | Why? |
| Diabetes Mellitus | 2 | 2021 | 8207 | 0.06 | Why? |
| Flow Cytometry | 2 | 2021 | 2393 | 0.06 | Why? |
| Neutrophils | 1 | 2018 | 5476 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2021 | 6153 | 0.06 | Why? |
| Pregnancy Complications, Infectious | 1 | 2007 | 11559 | 0.06 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 5002 | 0.06 | Why? |
| Differential Threshold | 1 | 2020 | 6 | 0.06 | Why? |
| Smell | 2 | 2020 | 1851 | 0.05 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.05 | Why? |
| Phylogeny | 1 | 2019 | 13341 | 0.05 | Why? |
| Partial Pressure | 1 | 2020 | 279 | 0.05 | Why? |
| RNA, Ribosomal, 18S | 1 | 2019 | 68 | 0.05 | Why? |
| Olfactory Perception | 1 | 2020 | 93 | 0.05 | Why? |
| Biomarkers | 5 | 2021 | 23361 | 0.05 | Why? |
| DNA, Protozoan | 1 | 2019 | 77 | 0.05 | Why? |
| Liver Abscess | 1 | 2019 | 42 | 0.05 | Why? |
| Streptomycin | 1 | 2018 | 8 | 0.05 | Why? |
| NADPH Oxidases | 1 | 2019 | 80 | 0.05 | Why? |
| Pilot Projects | 2 | 2021 | 5182 | 0.05 | Why? |
| Directly Observed Therapy | 1 | 2018 | 34 | 0.05 | Why? |
| Odorants | 1 | 2020 | 219 | 0.05 | Why? |
| Vasodilation | 1 | 2020 | 258 | 0.04 | Why? |
| Pennsylvania | 1 | 2020 | 558 | 0.04 | Why? |
| Coculture Techniques | 1 | 2018 | 258 | 0.04 | Why? |
| Prevalence | 4 | 2020 | 25773 | 0.04 | Why? |
| Tuberculosis Vaccines | 1 | 2018 | 89 | 0.04 | Why? |
| Isoniazid | 1 | 2017 | 105 | 0.04 | Why? |
| Drug Resistance, Multiple | 1 | 2018 | 156 | 0.04 | Why? |
| T-Lymphocytes, Helper-Inducer | 1 | 2020 | 497 | 0.04 | Why? |
| Blood Gas Analysis | 1 | 2020 | 893 | 0.04 | Why? |
| Antigens, Differentiation, Myelomonocytic | 1 | 2017 | 198 | 0.04 | Why? |
| Cells, Cultured | 2 | 2018 | 5835 | 0.04 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.04 | Why? |
| Sensitivity and Specificity | 3 | 2021 | 22971 | 0.04 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 7868 | 0.04 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.04 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.04 | Why? |
| Review Literature as Topic | 1 | 2018 | 387 | 0.03 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.03 | Why? |
| Th2 Cells | 1 | 2017 | 680 | 0.03 | Why? |
| Lymphocyte Subsets | 1 | 2021 | 987 | 0.03 | Why? |
| Receptors, Cell Surface | 1 | 2017 | 586 | 0.03 | Why? |
| Drug Monitoring | 1 | 2021 | 1408 | 0.03 | Why? |
| Alleles | 1 | 2019 | 1557 | 0.03 | Why? |
| Administration, Oral | 1 | 2020 | 2340 | 0.03 | Why? |
| Antigens, CD | 1 | 2017 | 984 | 0.03 | Why? |
| Antiretroviral Therapy, Highly Active | 1 | 2018 | 952 | 0.03 | Why? |
| Autoimmunity | 1 | 2019 | 841 | 0.03 | Why? |
| Cell Survival | 1 | 2017 | 1581 | 0.03 | Why? |
| Cell Differentiation | 1 | 2017 | 1338 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Interleukin-10 | 1 | 2018 | 1409 | 0.03 | Why? |
| Infant | 2 | 2019 | 30274 | 0.03 | Why? |
| Leukocyte Count | 1 | 2021 | 3178 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Sequence Analysis, DNA | 1 | 2019 | 2830 | 0.03 | Why? |
| Host-Pathogen Interactions | 2 | 2021 | 11041 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2018 | 1887 | 0.03 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.03 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2017 | 1115 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2021 | 2585 | 0.02 | Why? |
| Sputum | 1 | 2017 | 1720 | 0.02 | Why? |
| Cities | 1 | 2020 | 4937 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2017 | 2886 | 0.02 | Why? |
| Prisons | 1 | 2018 | 980 | 0.02 | Why? |
| Cross-Sectional Studies | 3 | 2021 | 53120 | 0.02 | Why? |
| Lymphocyte Activation | 1 | 2018 | 2742 | 0.02 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.02 | Why? |
| Interferon-gamma | 1 | 2018 | 2711 | 0.02 | Why? |
| Acute Disease | 1 | 2020 | 6029 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| Electrocardiography | 1 | 2021 | 3957 | 0.02 | Why? |
| Monocytes | 1 | 2018 | 2978 | 0.02 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.02 | Why? |
| Chronic Disease | 1 | 2020 | 5139 | 0.02 | Why? |
| Cohort Studies | 2 | 2020 | 36005 | 0.02 | Why? |
| Feces | 1 | 2019 | 4235 | 0.02 | Why? |
| Chiroptera | 1 | 2020 | 3530 | 0.02 | Why? |
| Lung Diseases | 1 | 2019 | 2361 | 0.02 | Why? |
| Pregnancy | 1 | 2007 | 23879 | 0.02 | Why? |
| Genetic Variation | 1 | 2019 | 3919 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2018 | 3614 | 0.02 | Why? |
| World Health Organization | 1 | 2018 | 4213 | 0.02 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3832 | 0.02 | Why? |
| Algorithms | 1 | 2020 | 7346 | 0.02 | Why? |
| Immunity, Innate | 1 | 2021 | 6570 | 0.01 | Why? |
| Skin Diseases | 1 | 2019 | 2509 | 0.01 | Why? |
| Occupational Exposure | 1 | 2021 | 4742 | 0.01 | Why? |
| Virus Internalization | 1 | 2021 | 7921 | 0.01 | Why? |
| Socioeconomic Factors | 1 | 2019 | 8495 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 11367 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 13720 | 0.01 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.01 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.01 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.01 | Why? |
| Animals | 2 | 2020 | 78931 | 0.01 | Why? |
| Hypertension | 1 | 2021 | 8895 | 0.01 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 9706 | 0.01 | Why? |
| Mass Screening | 1 | 2018 | 8005 | 0.01 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.01 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.01 | Why? |
| Child, Preschool | 1 | 2019 | 36283 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| United States | 1 | 2020 | 46150 | 0.01 | Why? |
| Child | 1 | 2019 | 70012 | 0.01 | Why? |